Soleil Boughton, Chief Legal Officer of Hims & Hers Health, Inc. (NYSE:HIMS), filed a Form 4 on October 29, 2026, disclosing the sale of 3,462 shares of Class A Common Stock on October 28, 2026.

Key Highlights

  • Reporting person: Soleil Boughton, Chief Legal Officer of Hims & Hers Health, Inc.
  • Transaction: Disposed of 3,462 shares of Class A Common Stock on October 28, 2026, at a price of $27.6 per share.
  • Post-transaction ownership: Boughton directly holds 293,886 shares of Class A Common Stock following the reported sale.
  • Rule 10b5-1 plan: The sale was made pursuant to a Rule 10b5-1 trading plan adopted by Boughton on May 21, 2026.
  • Filing signed: Kimberly Mather, Attorney-in-Fact for Soleil Boughton, signed the form on October 29, 2026.

Boughton's October 28 Share Disposition at Hims & Hers Health

According to the Form 4 filed with the SEC on October 29, 2026, Soleil Boughton, serving as Chief Legal Officer of Hims & Hers Health, Inc. (NYSE:HIMS), disposed of 3,462 shares of Class A Common Stock. The transaction was recorded on October 28, 2026, at a price of $27.6 per share. The filing classifies the transaction with code "S," indicating a sale, and confirms the shares were held and sold directly by the reporting person.

Following the reported transaction, the filing states that Boughton beneficially owns 293,886 shares of Class A Common Stock on a direct basis. No derivative securities transactions were reported in Table II of the filing.

The filing notes in its explanation of responses that "the sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 21, 2026 by the Reporting Person." The form also indicates, via the checked box on the cover, that the transaction was made pursuant to a contract, instruction, or written plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

What Was Disclosed

The Form 4 discloses that Chief Legal Officer Soleil Boughton sold 3,462 shares of Hims & Hers Health Class A Common Stock on October 28, 2026, at $27.6 per share under a pre-established Rule 10b5-1 trading plan, retaining direct ownership of 293,886 shares.